Rezolute Inc logo

Rezolute Inc

$ 2.74 +0.03 (+1.11%) 10:08 PM EST
P/E:
At Loss
P/B:
0.62
Market Cap:
$ 106.39M
Enterprise V:
$ -43.83M
Volume:
22.96K
Avg Vol (2M):
34.75K
Volume:
22.96K
Market Cap $:
106.39M
PE Ratio:
At Loss
Avg Vol (2-Month):
34.75K
Enterprise Value $:
-43.83M
PB Ratio:
0.62
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Rezolute Inc is a biopharmaceutical company. The company develops novel, sustained-release injectable therapies. It applies proprietary formulation and manufacturing capabilities to known, well-characterized molecules to create differentiated, patent-protected therapies that have the potential to significantly improve existing standards of care. Its pipeline products include RZ358 and RZ402.
Name Current Vs Industry Vs History
Cash-To-Debt 800.05
Equity-to-Asset 0.98
Debt-to-EBITDA -0.01
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score 0
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 50.13
9-Day RSI 51.54
14-Day RSI 50.84
6-1 Month Momentum % -29.59
12-1 Month Momentum % -68.18

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 61.78
Quick Ratio 61.78
Cash Ratio 61.09

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -99.8
Name Current Vs Industry Vs History
ROE % -65.95
ROA % -53.08
ROIC % -1412.65
ROC (Joel Greenblatt) % -14129.59
ROCE % -52.98

Financials (Next Earnings Date:2022-11-11 Est.)

RZLT's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:RZLT

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Embed

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0
EPS (TTM) ($) -2.772
Beta 1.7
Volatility % 72.99
14-Day RSI 50.84
14-Day ATR ($) 0.271249
20-Day SMA ($) 2.6255
12-1 Month Momentum % -68.18
52-Week Range ($) 2.06 - 8.19
Shares Outstanding (Mil) 38.83

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Rezolute Inc Filings

Document Form Filing Date
No Filing Data

Rezolute Inc Analysis

Share your research

Headlines

See More
No news.